Squamous Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Squamous Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Clinical trial update for necitumumab in first-line treatment of stage IV squamous non-small cell lung cancer (Phase 1/2) completed with res…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: AZD2014 and Weekly Paclitaxel in Squamous NSCLC [Phase 2]
A phase 2 trial evaluating AZD2014 in combination with weekly paclitaxel for squamous non-small cell lung cancer has been terminated; result…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating necitumumab plus chemotherapy in stage IV squamous non-small cell lung cancer has completed with results…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating gemcitabine/carboplatin with or without the PARP1 inhibitor in untreated stage IV squamous non-small cell lung canc…
-
FDA approval · 2015-11-24FDA Approved: PORTRAZZA — Original Application (Eli Lilly and Company)
FDA approved Portrazza (necitumumab) from Eli Lilly as an original application for first-line treatment of metastatic squamous non-small cel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.